• Indications
  • Open Access TIMES Journals
Login Register
Login Register
Indications
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Open Access TIMES Journals
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Ophthalmology

Ophthalmology

Case Reports
Webinar
Faculty
Homepage >
Ophthalmology >
Articles

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis

Uveitis
Share:
Do you want to read an article? Please log in or register.
Register for Free
Remember me
Forgot password? Click here
COMMENTED

Related content

Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol
Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH
doi: 10.1001/jamaophthalmol.2025.1455
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration
JAMA Ophthalmol
Ahuja AS, Paredes AA 3rd, Young BK
doi: 10.1001/jamaophthalmol.2025.3821
COMMENTED
Macular Diseases
Impact of Glucagon-like Peptide-1 Receptor Agonists on Age-Related Macular Degeneration at a Tertiary Ophthalmology Center
★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Joo JH, Zhao AH, Chalasani M, Allan KC, Rachitskaya AV
doi: 10.1016/j.oret.2025.12.014
Macular Diseases
Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapy
Ophthalmol Retina
Myers WK, Heath G, Rohrer B
doi: 10.1016/j.oret.2025.12.016
COMMENTED
Further Publications
Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis
★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care
Nogueira A, Rassi TNO, Iqbal A, Felix N, Alghaith O, Khan A, Rassi N, Maia M, Moura FA
doi: 10.2337/dc25-1238
COMMENTED
Macular DiseasesRetinal Diseases
Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database
★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Murray M, Schifano F, Chiappini S, Corkery JM, Guirguis A
doi: 10.1016/j.ajo.2025.12.015
Uveitis
Risk of Developing Pediatric Uveitis Among Patients With Early-Onset Atopic Dermatitis
JAMA Ophthalmol
Chu YY, Sung CH, Lin YS, Ho CH, Chen YC, Lee WA, Kuo SC
doi: 10.1001/jamaophthalmol.2025.0366
Retinal Diseases
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand
Pediatr Diabetes
Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL
doi: 10.1155/2024/5893771
  • Contact us
  • About us
  • Privacy Policy & Disclaimer
  • Online Media 2026 Data
  • Imprint
healthbook is a registered trademark. Copyright © 2026 healthbook